July 19, 2012 | Parexel International has been chosen by the Korea Drug Development Fund to help Korean biopharmaceutical companies develop and commercialize health care products for the global market. The fund is a consortium of three health-related Korean ministries: the Ministry of Knowledge Economy; the Ministry of Education, Science, and Technology; and the Ministry of Health and Welfare. Boston.com